401 related articles for article (PubMed ID: 26526896)
1. Co-transplantation of autologous bone marrow mesenchymal stem cells and Schwann cells through cerebral spinal fluid for the treatment of patients with chronic spinal cord injury: safety and possible outcome.
Oraee-Yazdani S; Hafizi M; Atashi A; Ashrafi F; Seddighi AS; Hashemi SM; Seddighi A; Soleimani M; Zali A
Spinal Cord; 2016 Feb; 54(2):102-9. PubMed ID: 26526896
[TBL] [Abstract][Full Text] [Related]
2. Safety and possible outcome assessment of autologous Schwann cell and bone marrow mesenchymal stromal cell co-transplantation for treatment of patients with chronic spinal cord injury.
Yazdani SO; Hafizi M; Zali AR; Atashi A; Ashrafi F; Seddighi AS; Soleimani M
Cytotherapy; 2013 Jul; 15(7):782-91. PubMed ID: 23731761
[TBL] [Abstract][Full Text] [Related]
3. Combining cell therapy with human autologous Schwann cell and bone marrow-derived mesenchymal stem cell in patients with subacute complete spinal cord injury: safety considerations and possible outcomes.
Oraee-Yazdani S; Akhlaghpasand M; Golmohammadi M; Hafizi M; Zomorrod MS; Kabir NM; Oraee-Yazdani M; Ashrafi F; Zali A; Soleimani M
Stem Cell Res Ther; 2021 Aug; 12(1):445. PubMed ID: 34372939
[TBL] [Abstract][Full Text] [Related]
4. Safety and neurological assessments after autologous transplantation of bone marrow mesenchymal stem cells in subjects with chronic spinal cord injury.
Mendonça MV; Larocca TF; de Freitas Souza BS; Villarreal CF; Silva LF; Matos AC; Novaes MA; Bahia CM; de Oliveira Melo Martinez AC; Kaneto CM; Furtado SB; Sampaio GP; Soares MB; dos Santos RR
Stem Cell Res Ther; 2014 Nov; 5(6):126. PubMed ID: 25406723
[TBL] [Abstract][Full Text] [Related]
5. Image-guided percutaneous intralesional administration of mesenchymal stromal cells in subjects with chronic complete spinal cord injury: a pilot study.
Larocca TF; Macêdo CT; Souza BSF; Andrade-Souza YM; Villarreal CF; Matos AC; Silva DN; da Silva KN; de Souza CLEM; Paixão DDS; Bezerra MDR; Alves RL; Soares MBP; Dos Santos RR
Cytotherapy; 2017 Oct; 19(10):1189-1196. PubMed ID: 28760352
[TBL] [Abstract][Full Text] [Related]
6. Safety of Autologous Human Schwann Cell Transplantation in Subacute Thoracic Spinal Cord Injury.
Anderson KD; Guest JD; Dietrich WD; Bartlett Bunge M; Curiel R; Dididze M; Green BA; Khan A; Pearse DD; Saraf-Lavi E; Widerström-Noga E; Wood P; Levi AD
J Neurotrauma; 2017 Nov; 34(21):2950-2963. PubMed ID: 28225648
[TBL] [Abstract][Full Text] [Related]
7. Treatment of chronic thoracic spinal cord injury patients with autologous Schwann cell transplantation: an interim report on safety considerations and possible outcomes.
Saberi H; Moshayedi P; Aghayan HR; Arjmand B; Hosseini SK; Emami-Razavi SH; Rahimi-Movaghar V; Raza M; Firouzi M
Neurosci Lett; 2008 Sep; 443(1):46-50. PubMed ID: 18662744
[TBL] [Abstract][Full Text] [Related]
8. Chronic spinal cord injury treated with transplanted autologous bone marrow-derived mesenchymal stem cells tracked by magnetic resonance imaging: a case report.
Chotivichit A; Ruangchainikom M; Chiewvit P; Wongkajornsilp A; Sujirattanawimol K
J Med Case Rep; 2015 Apr; 9():79. PubMed ID: 25885347
[TBL] [Abstract][Full Text] [Related]
9. Safety and feasibility of autologous olfactory ensheathing cell and bone marrow mesenchymal stem cell co-transplantation in chronic human spinal cord injury: a clinical trial.
Zamani H; Soufizomorrod M; Oraee-Yazdani S; Naviafar D; Akhlaghpasand M; Seddighi A; Soleimani M
Spinal Cord; 2022 Jan; 60(1):63-70. PubMed ID: 34504283
[TBL] [Abstract][Full Text] [Related]
10. Intravenous infusion of auto serum-expanded autologous mesenchymal stem cells in spinal cord injury patients: 13 case series.
Honmou O; Yamashita T; Morita T; Oshigiri T; Hirota R; Iyama S; Kato J; Sasaki Y; Ishiai S; Ito YM; Namioka A; Namioka T; Nakazaki M; Kataoka-Sasaki Y; Onodera R; Oka S; Sasaki M; Waxman SG; Kocsis JD
Clin Neurol Neurosurg; 2021 Apr; 203():106565. PubMed ID: 33667953
[TBL] [Abstract][Full Text] [Related]
11. Schwann cell transplantation for spinal cord injury repair: its significant therapeutic potential and prospectus.
Kanno H; Pearse DD; Ozawa H; Itoi E; Bunge MB
Rev Neurosci; 2015; 26(2):121-8. PubMed ID: 25581750
[TBL] [Abstract][Full Text] [Related]
12. Intrathecal administration of autologous mesenchymal stromal cells for spinal cord injury: Safety and efficacy of the 100/3 guideline.
Vaquero J; Zurita M; Rico MA; Aguayo C; Bonilla C; Marin E; Tapiador N; Sevilla M; Vazquez D; Carballido J; Fernandez C; Rodriguez-Boto G; Ovejero M;
Cytotherapy; 2018 Jun; 20(6):806-819. PubMed ID: 29853256
[TBL] [Abstract][Full Text] [Related]
13. Long-term results of spinal cord injury therapy using mesenchymal stem cells derived from bone marrow in humans.
Park JH; Kim DY; Sung IY; Choi GH; Jeon MH; Kim KK; Jeon SR
Neurosurgery; 2012 May; 70(5):1238-47; discussion 1247. PubMed ID: 22127044
[TBL] [Abstract][Full Text] [Related]
14. Continuous improvement after multiple mesenchymal stem cell transplantations in a patient with complete spinal cord injury.
Jarocha D; Milczarek O; Wedrychowicz A; Kwiatkowski S; Majka M
Cell Transplant; 2015; 24(4):661-72. PubMed ID: 25807231
[TBL] [Abstract][Full Text] [Related]
15. Role of bone marrow derived mesenchymal stromal cells and Schwann-like cells transplantation on spinal cord injury in adult male albino rats.
Galhom RA; Hussein Abd El Raouf HH; Mohammed Ali MH
Biomed Pharmacother; 2018 Dec; 108():1365-1375. PubMed ID: 30372839
[TBL] [Abstract][Full Text] [Related]
16. Clinical safety and primary efficacy of bone marrow mesenchymal cell transplantation in subacute spinal cord injured patients.
Karamouzian S; Nematollahi-Mahani SN; Nakhaee N; Eskandary H
Clin Neurol Neurosurg; 2012 Sep; 114(7):935-9. PubMed ID: 22464434
[TBL] [Abstract][Full Text] [Related]
17. Autologous mesenchymal stromal cell transplantation for spinal cord injury: A Phase I pilot study.
Satti HS; Waheed A; Ahmed P; Ahmed K; Akram Z; Aziz T; Satti TM; Shahbaz N; Khan MA; Malik SA
Cytotherapy; 2016 Apr; 18(4):518-22. PubMed ID: 26971680
[TBL] [Abstract][Full Text] [Related]
18. Phase 1 Safety Trial of Autologous Human Schwann Cell Transplantation in Chronic Spinal Cord Injury.
Gant KL; Guest JD; Palermo AE; Vedantam A; Jimsheleishvili G; Bunge MB; Brooks AE; Anderson KD; Thomas CK; Santamaria AJ; Perez MA; Curiel R; Nash MS; Saraf-Lavi E; Pearse DD; Widerström-Noga E; Khan A; Dietrich WD; Levi AD
J Neurotrauma; 2022 Feb; 39(3-4):285-299. PubMed ID: 33757304
[TBL] [Abstract][Full Text] [Related]
19. Bone marrow stem cells and polymer hydrogels--two strategies for spinal cord injury repair.
Syková E; Jendelová P; Urdzíková L; Lesný P; Hejcl A
Cell Mol Neurobiol; 2006; 26(7-8):1113-29. PubMed ID: 16633897
[TBL] [Abstract][Full Text] [Related]
20. Clinical analysis of the treatment of spinal cord injury with umbilical cord mesenchymal stem cells.
Liu J; Han D; Wang Z; Xue M; Zhu L; Yan H; Zheng X; Guo Z; Wang H
Cytotherapy; 2013 Feb; 15(2):185-91. PubMed ID: 23321330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
